Mount Yale Investment Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Sell
5,714
-5,374
-48% -$1.43M 0.05% 342
2026
Q1
$1.22M Buy
+11,088
New +$1.58M 0.03% 479
2025
Q3
– Sell
-9,532
Closed -$862K – 1646
2025
Q2
$862K Buy
9,532
+2,418
+34% +$191K 0.07% 236
2025
Q1
$424K Buy
7,114
+4,167
+141% +$385K 0.04% 360
2024
Q4
$390K Sell
2,947
-8,392
-74% -$788K 0.03% 381
2024
Q3
$594K Buy
+11,339
New +$532K 0.06% 307

Other funds holding ALAB

Mount Yale Investment Advisors's ALAB Position: Q2 2026 in Review

Mount Yale Investment Advisors reduced its Astera Labs (ALAB) stake by 48% in Q2 2026, selling an estimated $1.43M and leaving 5,714 shares worth $2.76M. The position accounts for 0.05% of the portfolio, ranked #342.

Mount Yale Investment Advisors first reported a position in ALAB in Q3 2024 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Mount Yale Investment Advisors held 5,714 shares of Astera Labs worth $2.76M as of Q2 2026.
  • Mount Yale Investment Advisors sold 5,374 Astera Labs shares in Q2 2026, an estimated $1.43M.
  • Astera Labs made up 0.05% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #342 holding.
  • Mount Yale Investment Advisors first reported a position in Astera Labs in Q3 2024 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.